Chapter 45 : Enteroviruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in

Enteroviruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815981/9781555814250_Chap45-1.gif /docserver/preview/fulltext/10.1128/9781555815981/9781555814250_Chap45-2.gif


The original taxonomic classification of the enteroviruses (EVs) recognized 64 prototype serotypes within the family . The majority of what is known about the pathogenesis of EV infections in humans has been based on the study of the polioviruses, the prototypic members of the genus, in experimental infections using chimpanzees more than four decades ago and, most recently, from transgenic mice expressing the poliovirus receptor CD155. The study of cell-mediated immune responses to EVs has been much more limited, and the importance of the cellular response in preventing or clearing infection is still unclear. A 20-year evaluation of the epidemiology of neonatal EV infections identified case fatality rates that ranged from approximately 17 to 20% for infants <1 month of age infected with echoviruses 6, 11, 20, and 30 and coxsackievirus B4. The clinical manifestations of EV-associated upper respiratory infections (URIs), otitis media, wheezing, and pharyngotonsillitis are indistinguishable from those due to other respiratory viruses. Although it is the most sensitive method for laboratory diagnosis of some coxsackievirus A infections, isolation of EVs in suckling mice is rarely performed any longer because of the difficulties of the technique and of animal maintenance. As with other viral pathogens, there are several steps in the replication cycle of the picornaviruses that are potential targets in antiviral therapy. Cell susceptibility, viral attachment, viral uncoating, viral RNA replication, and viral protein synthesis have all been studied as targets of antipicornaviral compounds.

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45

Key Concept Ranking

Viral Life Cycle
Upper Respiratory Tract Infections
Nucleic Acid Amplification Techniques
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

(a) Schematic representation of the icosahedral viral capsid structure of the EV. The fivefold (5x) and threefold (3x) axes of symmetry are indicated, as is the position of one of the 60 repeating protomeric units, each comprised of VP1, VP2, and VP3 surface proteins. (b) Line drawing of the VP1 and VP2 proteins in their tertiary configuration. The canyon structure, into which the cellular receptor for the EVs fits, is illustrated with its sphingosine (sph) hydrocarbon-binding pocket. (Reprinted from reference with permission.)

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2

Genomic organization and translation products of the EVs, as represented by poliovirus. The cross-hatched circle indicates the covalently attached VPg molecule at the 5′ end of the RNA. The coding region (nt 743 to 7370 on this map) is shown as a thick line. The poly(A) tail at the 3′ end of the RNA is indicated by “A.” The polyprotein coded for by the single ORF is then posttranslationally modified by viral proteases to form the viral protein cleavage products. (Reprinted from reference with permission.)

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3

Cytopathic effect of poliovirus type 1 infection of tissue culture cells. (panel 1) Uninfected rhesus monkey kidney cells. (panel 2) Poliovirus-infected rhesus monkey kidney cells 24 h after infection. (panel 3) Uninfected HEp-2 cells. (panel 4) Poliovirus-infected HEp-2 cells 24 h after infection. (Reprinted from reference with permission.)

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4

In situ hybridization study of an adult patient with EV myocarditis. Darkly staining cells indicate the presence of EV RNA. Infection is seen within the inflammatory infiltrate (A and B) as well as in nearby myocardial muscle cells (C). (Reprinted from reference .)

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5

Natural history of EV aseptic meningitis. Comp. Fix., complement fixation. (Reprinted from reference with permission.)

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6

Clinical features of young infants with EV infections and the relationship of those features to the infecting serotype (echoviruses [ECHO] versus coxsackieviruses [COXSACKIE B], top panel) and to the presence or absence of meningitis (bottom panel). LRI, lower respiratory infection; URI, upper respiratory infection. (Reprinted from reference with permission.)

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 7

Herpangina due to coxsackie A viruses. Small, discrete vesicles surrounded by erythema are seen on the palate and uvula and elsewhere in the posterior oropharynx.

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 8

Characteristic lesions of EV hand-foot-and-mouth syndrome involving the dorsum of the hand and fingers.

Citation: Romero J. 2009. Enteroviruses, p 1031-1061. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch45
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Abdel-Rahman, S. M.,, and G. L. Kearns. 1999. Single oral dose escalation pharmacokinetics of pleconaril capsules in adults. J. Clin. Pharmacol. 39:613618.
2. Abzug, M. J. 2004. Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatr. Drugs 6:110.
3. Abzug, M. J.,, G. Cloud,, J. Bradley,, P. J. Sánchez,, J. Romero,, D. Powell,, M. Lepow,, C. Mani,, E. V. Capparelli,, S. Blount,, F. Lakeman,, R. J. Whitley, and, D. W. Kimberlin for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 2003. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr. Infect. Dis. J. 22:335341.
4. Abzug, M. J.,, M. J. Levin, and, H. A. Rotbart. 1993. Profile of enterovirus disease in the first two weeks of life. Pediatr. Infect. Dis. J. 12:820824.
5. Andino, R.,, G. E. Rieckhof,, P. L. Achacoso, and, D. Baltimore. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J. 12:35873598.
6. Antona, D.,, N. Leveque,, J. J. Chomel,, S. Dubrou,, D. Levy-Bruhl, and, B. Lina. 2007. Surveillance of enteroviruses in France, 2000–2004. Eur. J. Clin. Microbiol. Infect. Dis. 26:403412.
7. Aretz, H. T. 1987. Myocarditis: the Dallas criteria. Hum. Pathol. 18:619624.
8. Ashwell, M. J.,, D. W. Smith,, P. A. Phillips, and, I. L. Rouse. 1996. Viral meningitis due to echovirus types 6 and 9: epidemiological data from Western Australia. Epidemiol. Infect. 117:507512.
9. Auld, P. A. M.,, S. V. Kevy, and, R. C. Eley. 1960. Poliomyelitis in children: experience with 956 cases in the 1955 Massachusetts epidemic. N. Engl. J. Med. 263:10931100.
10. Badorff, C.,, G. H. Lee,, B. J. Lamphear,, M. E. Martone,, K. P. Campbell,, R. E. Rhoads, and, K. U. Knowlton. 1999. Enteroviral protease 2A cleaves dystrophin: evidence of a cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 5:320326.
11. Baker, R. C.,, A. W. Kummer,, J. R. Schultz,, H. Ho, and, J. Gonzalez del Rey. 1996. Neurodevelopmental outcome of infants with viral meningitis in the first three months of life. Clin. Pediatr. 35:295301.
12. Balfour, H. H.,, Jr., G. L. Seifert,, M. H. Seifert, Jr.,, P. G. Quie,, C. K. Edelman,, H. Bauer, and, R. A. Siem. 1973. Meningoencephalitis and laboratory evidence of triple infection with California encephalitis virus, echovirus 11 and mumps. Pediatrics 51:680684.
13. Banatvala, J. E. 1987. Insulin-dependent (juvenile-onset, type 1) diabetes mellitus and coxsackie B viruses revisited. Prog. Med. Virol. 34:3354.
14. Barrett-Connor, E. 1985. Is insulin-dependent diabetes mellitus caused by coxsackie virus B infection? A review of the epidemiologic evidence. Rev. Infect. Dis. 7:207215.
15. Belnap, D. M.,, D. J. Filman,, B. L. Trus,, N. Cheng,, F. P. Booy,, J. F. Conway,, S. Curry,, C. N. Hiremath,, S. K. Tsang,, A. C. Steven, and, J. M. Hogle. 2000. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J. Virol. 74:13421354.
16. Bendig, J.,, and P. Earl. 2005. The Lim Benyesh-Melnick antiserum pools for serotyping human enterovirus cell culture isolates—still useful, but may fail to identify current strains of echovirus 18. J. Virol. Methods 127:9699.
17. Bendinelli, M.,, and A. Ruschi. 1969. Isolation of human enterovirus from mussels. Appl. Microbiol. 18:531532.
18. Bergelson, J. M.,, J. A. Cunningham,, G. Droguett,, E. A. Kurt-Jones,, A. Krithivas,, J. S. Hong,, M. S. Horwitz,, R. L. Crowell, and, R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:13201323.
19. Bergman, I.,, M. J. Painter,, E. R. Wald,, D. Chiponis,, A. L. Holland, and, H. G. Taylor. 1987. Outcome in children with enteroviral meningitis during the first year of life. J. Pediatr. 110:705709.
20. Berlin, L. E.,, M. L Rorabaugh,, F. Heidrich,, K. Roberts,, T. Doran, and, J. F. Modlin. 1993. Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J. Infect. Dis. 168:888892.
21. Bodian, D. 1949. Histopathologic basis of the clinical findings in poliomyelitis. Am. J. Med. 6:563.
22. Bodian, D. 1952. Pathogenesis of poliomyelitis. Am. J. Public Health 42:13881402.
23. Bodian, D. 1955. Emerging concept of poliomyelitis infection. Science 122:105108.
24. Boivin, G.,, A. D. Osterhaus,, A. Gaudreau,, H. C. Jackson,, J. Groen, and, P. Ward. 2002. Role of picornaviruses in flu-like illnesses of adults enrolled in an oseltamivir treatment study who had no evidence of influenza virus infection. J. Clin. Microbiol. 40:330334.
25. Bowles, N. E.,, T. A. Bayston,, H. Y. Zhang,, D. Doyle,, R. J. Lane,, L. Cunningham, and, L. C. Archard. 1993. Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy. J. Med. 24:145160.
26. Bradrick, S. S.,, E. A. Lieben,, B. M. Carden, and, J. R. Romero. 2001. A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell-type-specific block to viral replication. J. Virol. 75:64726481.
27. Brown, B. A.,, D. R. Kilpatrick,, M. S. Oberste, and, M. A. Pallansch. 2000. Serotype-specific identification of enterovirus 71 by PCR. J. Clin. Virol. 16:107112.
28. Bubeck, D. D.,, J. Filman,, N. Cheng,, A. C. Steven,, J. M. Hogle, and, D. M. Belnap. 2005. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J. Virol. 79:77457755.
29. Caggana, M.,, P. Chan, and, A. Ramsingh. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:47974803.
30. Capaul, S. E.,, and M. Gorgievski-Hrisoho. 2005. Detection of enterovirus RNA in cerebrospinal fluid (CSF) using NucliSens EasyQ Enterovirus assay. J. Clin. Virol. 32:236240.
31. Carrol, E. D.,, M. B. Beadsworth,, N. Jenkins,, L. Ratcliffe,, I. Ashton,, B. Crowley,, F. J. Nye, and, N. J. Beeching. 2006. Clinical and diagnostic findings of an echovirus meningitis outbreak in the northwest of England. Postgrad. Med. J. 82:6064.
32. Centers for Disease Control and Prevention. 2001. Apparent global interruption of wild poliovirus type 2 transmission. Morb. Mortal. Wkly. Rep. 50:222.
33. Centers for Disease Control and Prevention. 2005. Summary of notifiable diseases—United States. Morb. Mortal. Wkly. Rep. 54:192.
34. Centers for Disease Control and Prevention. 2005. Poliovirus infections in four unvaccinated children—Minnesota, August–October. Morb. Mortal. Wkly. Rep. 54:10531055.
35. Centers for Disease Control and Prevention. 2006. Imported vaccine-associated paralytic poliomyelitis—United States. Morb. Mortal. Wkly. Rep. 55:9799.
36. Centers for Disease Control and Prevention. 2006. Progress toward interruption of wild poliovirus transmission—worldwide, January 2005–March 2006. Morb. Mortal. Wkly. Rep. 55:458462.
37. Centers for Disease Control and Prevention. 2006. Enterovirus surveillance—United States, 1970–2005. Morb. Mortal. Wkly. Rep. 55:120.
38. Centers for Disease Control and Prevention. 2007. Progress toward interruption of wild poliovirus transmission—worldwide, January 2006–May 2007. Morb. Mortal. Wkly. Rep. 56:682685.
39. Centers for Disease Control and Prevention. 2007. Update on vaccine-derived polioviruses—worldwide, January 2006–August 2007. Morb. Mortal. Wkly. Rep. 56:9961001.
40. Chang, L. Y.,, L. M. Huang,, S. S. Gau,, Y. Y. Wu,, S. H. Hsia,, T. Y. Fan,, K. L. Lin,, Y. C. Huang,, C. Y. Lu, and, T. Y. Lin. 2007. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 356:12261234.
41. Chapman, N. M.,, S. Tracy,, C. J. Gauntt, and, U. Fortmueller. 1990. Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. J. Clin. Microbiol. 28:843850.
42. Chemtob, S.,, E. R. Reece, and, E. L. Mills. 1985. Syndrome of inappropriate secretion of antidiuretic hormone in enteroviral meningitis. Am. J. Dis. Child. 139:292294.
43. Cherry, J. D. 2004. Enteroviruses and parechoviruses, p. 1984–2041. In R. D. Feigin,, J. D. Cherry,, G. J. Demmler, and, S. L. Kaplan (ed.), Textbook of Pediatric Infectious Diseases, 5th ed. W. B. Saunders, Philadelphia, PA.
44. Cherry, J. D.,, and C. L. Jahn. 1965. Herpangina: the etiologic spectrum. Pediatrics 36:632634.
45. Chesney, J. C.,, G. E. Hoganson, and, M. H. Wilson. 1980. CSF eosinophilia during an acute coxsackie B4 viral meningitis. Am. J. Dis. Child. 134:703.
46. Chonmaitree, T.,, and L. Mann. 1995. Respiratory infections, p. 255–270. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
47. Chonmaitree, T.,, M. A. Menegus, and, K. R. Powell. 1982. The clinical relevance of CSF viral culture. A two-year experience with aseptic meningitis in Rochester, New York. JAMA 247:18431847.
48. Chou, S. M.,, and L. Gutmann. 1970. Picornavirus-like crystals in subacute polymyositis. Neurology 20:205213.
49. Chung, J. Y.,, T. H. Han,, S. W. Kim, and, E. S. Hwang. 2007. Respiratory picornavirus infections in Korean children with lower respiratory tract infections. Scand. J. Infect. Dis. 39:250254.
50. Clements, G. B.,, D. N. Galbraith, and, K. W. Taylor. 1995. Coxsackie B virus infection and onset of childhood diabetes. Lancet 346:221223.
51. Committee on the Enteroviruses. 1962. The enteroviruses. Virology 16:501504.
52. Coyne, C. B.,, and J. M. Bergelson. 2006. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124:119131.
53. Craig, M. E.,, P. Robertson,, N. J. Howard,, M. Silink, and, W. D. Rawlinson. 2003. Diagnosis of enterovirus infection by genus-specific PCR and enzyme-linked immunosorbent assays. J. Clin. Microbiol. 41:841844.
54. Cree, B. C.,, G. L. Bernardini,, A. P. Hays, and, G. Lowe. 2003. A fatal case of coxsackievirus B4 meningoencephalitis. Arch. Neurol. 60:107112.
55. Crespo-Leiro, M. G.,, M. Hermida-Prieto,, F. Peña,, F. Portela,, J. Muñiz,, L. F. Hermida,, A. Juffe-Stein, and, A. Castro-Beiras. 2000. Absence of enteroviral RNA in hearts explanted from patients with dilated cardiomyopathy. J. Heart Lung Transplant. 19:134138.
56. Dagan, R.,, and M. A. Menegus. 1995. Nonpolic enteroviruses and the febrile infant, p. 239–254. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
57. Dagan, R.,, J. A. Jenista, and, M. A. Menegus. 1988. Association of clinical presentation, laboratory findings, and virus serotypes with the presence of meningitis in hospitalized infants with enterovirus infections. J. Pediatr. 113:975978.
58. Dagan, R.,, and M. A. Menegus. 1992. Replication of enteroviruses in human mononuclear cells. lsr. J. Med. Sci. 28:369372.
59. Dahlquist, G. G.,, S. Ivarsson,, B. Lindberg, and, M. Forsgren. 1995. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based control study. Diabetes 44:408413.
60. Dai-Ming, W.,, Z. Guo-Chang, and, Z. Shi-Mei. 1993. An epidemic of encephalitis and meningoencephalitis in children caused by echovirus type 30 in Shanghai. Chin. Med. J. 106:767769.
61. Dalakas, M. C. 1995. Enteroviruses and human neuromuscular diseases, p. 387–398. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
62. Dalakas, M. C.,, H. Bartfield, and, T. Kurland (ed.). 1995. Annals of the New York Academy of Sciences, vol. 753. The Post-Polio Syndrome: Advances in the Pathogenesis and Treatment. New York Academy of Sciences, New York, NY.
63. Dalakas, M. C.,, J. L. Sever,, D. L. Madden,, N. M. Papadopoulos,, I. C. Shekarchi,, P. Albrecht, and, A. Krezlewicz. 1984. Late post-poliomyelitis muscular atrophy: clinical, virological, and immunological studies. Rev. Infect. Dis. 6:55625567.
64. de Quadros, C. A.,, J. K. Andrus,, J. M. Olive,, C. Guerra de Macedo, and, D. A. Henderson. 1992. Polio eradication from the Western Hemisphere. Annu. Rev. Public Health 13:239252.
65. Desmond, R. A.,, N. A. Accortt,, L. Talley,, S. A. Villano,, S. J. Soong, and, R. J. Whitley. 2006. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob. Agents Chemother. 50:24092414.
66. Dietz, V.,, J. Andrus,, J. M. Olive,, S. Cochi, and, C. de Quadros. 1995. Epidemiology and clinical characteristics of acute flaccid paralysis associated with non-polio enterovirus isolation: the experience in the Americas. Bull. W. H. O. 73:597603.
67. Douche-Aourik, F.,, W. Berlier,, L. Féasson,, T. Bourlet,, R. Harrath,, S. Omar,, F. Grattard,, C. Denis, and, B. Pozzetto. 2003. Detection of enterovirus in human skeletal muscle from patients with chronic inflammatory muscle disease or fibromyalgia and healthy subjects. J. Med. Virol. 71:540547.
68. Dunn, J. J.,, S. S. Bradrick,, N. M. Chapman,, S. M. Tracy, and, J. R. Romero. 2003. The stem loop II within the 5′ nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. J. Infect. Dis. 187:15521561.
69. Dunn, J. J.,, N. M. Chapman,, S. Tracy, and, J. R. Romero. 2000. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. J. Virol. 74:47874794.
70. Eberle, K. E.,, V. T. Nguyen, and, M. S. Freistadt. 1995. Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes. Arch. Virol. 140:21352150.
71. Efter, C. G.,, J. Wedgwood, and, U. B. Schaad. 1991. Aseptische Meningitiden in der Padiatrie. Schweiz. Med. Wochenschr. 121:11201126.
72. Eglin, R. P.,, R. A. Swann,, D. Isaacs, and, E. R. Moxon. 1984. Simultaneous bacterial and viral meningitis. Lancet ii:984.
73. Enders, J. F.,, T. H. Weller, and, F. C. Robbins. 1949. Cultivation of the Lansing strain of poliomyelitis virus in culture of various human embryonic tissues. Science 109:8599.
74. Farmer, K.,, G. A. MacArthur, and, M. M. Clay. 1975. A follow-up study of 15 cases of neonatal meningoencephalitis due to coxsackie virus B5. J. Pediatr. 87:568571.
75. Faulkner, R. S.,, A. J. MacLeod, and, C. E. Van Rooyen. 1957. Virus meningitis—seven cases in one family. Can. Med. Assoc. J. 77:439444.
76. Fox, J. P.,, C. E. Hall,, M. K. Cooney,, R. E. Luce, and, R. A. Kronmal. 1972. The Seattle virus watch. II. Objectives, study population and its observation, data processing and summary of illnesses. Am. J. Epidemiol. 98:270285.
77. Fox, M. P.,, M. A. McKinlay,, G. D. Diana, and, F. J. Dutko. 1991. Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14. Antimicrob. Agents Chemother. 35:10401047.
78. Freistadt, M. S.,, G. Kaplan, and, V. R. Racaniello. 1990. Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol. Cell. Biol. 10:57005706.
79. Gamble, D. R.,, and K. W. Taylor. 1969. Seasonal incidence of diabetes mellitus. Br. Med. J. 3:631633.
80. Gatmaitan, B. G.,, J. L. Chason, and, A. M. Lerner. 1970. Augmentation of the virulence of murine coxsackievirus B-3 myocardiopathy by exercise. J. Exp. Med. 131:11211136.
81. Gear, J. H. 1984. Nonpolio causes of polio-like paralytic syndromes. Rev. Infect. Dis. 6(Suppl. 2):S379S384.
82. Ginocchio, C. C. 2005. Development, technical performance, and clinical evaluation of a NucliSens basic kit application for detection of enterovirus RNA in cerebrospinal fluid. J. Clin. Microbiol. 43:26162623.
83. Graves, P. M.,, H. A. Rotbart,, W. A. Nix,, M. A. Pallansch,, H. A. Erlich,, J. M. Norris,, M. Hoffman,, G. S. Eisenbarth, and, M. Rewers. 2003. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res. Clin. Pract. 59:5161.
84. Grimwood, K.,, Q. S. Huang,, L. G. Sadleir,, W. A. Nix,, D. R. Kilpatrick,, M. S. Oberste, and, M. A. Pallansch. 2003. Acute flaccid paralysis from echovirus type 33 infection. J. Clin. Microbiol. 41:22302232.
85. Grist, N. R.,, E. J. Bell, and, F. Assaad. 1978. Enteroviruses in human disease. Prog. Med. Virol. 24:114157.
86. Grist, N. R.,, and E. J. Bell. 1984. Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland. Rev. Infect. Dis. 6(Suppl. 2):S385S386.
87. Gromeier, M.,, and A. Nomoto. 2002. Determinants of poliovirus pathogenesis, p. 367–379. In B. L. Semler and, E. Wimmer (ed.), Molecular Biology of Picornaviruses. ASM Press, Washington, DC.
88. Gromeier, M.,, and E. Wimmer. 1998. Mechanism of injury-provoked poliomyelitis. J. Virol. 72:50565060.
89. Guarner, J.,, J. Bhatnagar,, W. J. Shieh,, K. B. Nolte,, D. Klein,, M. S. Gookin,, S. Peñaranda,, M. S. Oberste,, T. Jones,, C. Smith,, M. A. Pallansch, and, S. R. Zaki. 2007. Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis. Hum. Pathol. 38:1412.
90. Gutierrez, K. M.,, and M. J. Abzug. 1990. Vaccine-associated poliovirus meningitis in children with ventriculoperitoneal shunts. J. Pediatr. 117:424427.
91. Haller, A. A.,, and B. L. Semler. 1995. Translation and host cell shutoff, p. 113–133. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
92. Hawley, H. B.,, D. P. Morin,, M. E. Geraghty,, J. Tomkow, and, C. A. Phillips. 1973. Coxsackievirus B epidemic at a boy’s summer camp. Isolation of virus from swimming water. JAMA 226:3336.
93. Hendry, E.,, H. Hatanaka,, E. Fry,, M. Smyth,, J. Tate,, G. Stanway,, J. Santti,, M. Maaronen,, T. Hyypiä, and, D. Stuart. 1999. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure 7:15271538.
94. Hierholzer, J. C.,, K. A. Hilliard, and, J. J. Esposito. 1975. Serosurvey for “acute hemorrhagic conjunctivitis” virus (enterovirus 70) antibodies in the southeastern United States, with review of the literature and some epidemiologic implications. Am. J. Epidemiol. 102:533544.
95. Ho, M.,, E. R. Chen,, K. H. Hsu,, S. J. Twu,, K. T. Chen,, S. F. Tsai,, J. R. Wang, and, S. R. Shih. 1999. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341:929935.
96. Hogle, J. M.,, M. Chow, and, D. J. Filman. 1985. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229:13581365.
97. Horstmann, D. M. 1949. Clinical aspects of acute poliomyelitis. Am. J. Med. 6:592.
98. Horstmann, D. M. 1950. Acute poliomyelitis: relation of physical activity at the time of onset to the course of the disease. JAMA 142:236241.
99. Horstmann, D. M.,, and N. Yamada. 1968. Enterovirus infections of the central nervous system. Res. Publ. Assoc. Nerv. Ment. Dis. 44:236253.
100. Hosoya, M.,, M. Sato,, K. Honzumi,, M. Katayose,, Y. Kawasaki,, H. Sakuma,, K. Kato,, Y. Shimada,, H. Ishiko, and, H. Suzuki. 2001. Association of nonpolio enteroviral infection in the central nervous system of children with febrile seizures. Pediatrics 107:E12.
101. Howden, C. W.,, W. R. Lang, and, J. Laws. 1966. An epidemic of ECHO 9 virus meningitis in Auckland. N. Z. Med. J. 65:763765.
102. Hsiung, G. O. 1995. Enteroviruses. In G. D. Hsiung (ed.), Diagnostic Virology. Yale University Press, New Haven, CT.
103. Huang, C. C.,, C. C. Liu,, Y. C. Chang,, C. Y. Chen,, S. T. Wang, and, T. F. Yeh. 1999. Neurologic complications in children with enterovirus 71 infections. N. Engl. J. Med. 341:936942.
104. Huang, M. C.,, S. M. Wang,, Y. W. Hsu,, H. C. Lin,, C. Y. Chi, and, C. C. Liu. 2006. Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children. Pediatrics 118:e1785e1788.
105. Huber, S. A.,, C. Haisch, and, P. A. Lodge. 1990. Functional diversity in vascular endothelial cells—role in coxsackievirus tropism. J. Virol. 64:45164522.
106. Huebner, R. J.,, J. A. Risser,, J. A. Bell,, E. A. Beeman,, P. M. Beigelman, and, J. C. Strong. 1953. Epidemic pleurodynia in Texas; a study of 22 cases. N. Engl. J. Med. 248:267274.
107. Hughes, P. J.,, C. Horsnell,, T. Hyypiä, and, G. Stanway. 1991. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J. Virol. 65:47354740.
108. Hurst, E. W. 1936. The newer knowledge of virus diseases of the nervous system: a review and an interpretation. Brain 59:134.
109. Hyypia, T.,, P. Auvinen, and, M. Maaronen. 1989. Polymerase chain reaction for human picornaviruses. J. Gen. Virol. 70:32613268.
110. Hyypia, T.,, C. Horsnell,, M. Maaronen,, M. Khan,, N. Kalkkinen,, P. Auvinen,, L. Kinnunen, and, G. Stanway. 1992. A distinct picornavirus group identified by sequence analysis. Proc. Natl. Acad. Sci. USA 89:88478851.
111. Ida-Hosonuma, M.,, T. Iwasaki,, T. Yoshikawa,, N. Nagata,, Y. Sato,, T. Sata,, M. Yoneyama,, T. Fujita,, C. Taya,, H. Yonekawa, and, S. Koike. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79:44604469.
112. Irvine, D. H.,, A. B. H. Irvine, and, P. S. Gardner. 1967. Outbreak of ECHO virus type 30 in a general practice. Br. Med. J. 4:774776.
113. Isacsohn, M.,, A. L. Eidelman,, M. Kaplan,, A. Goren,, B. Rudensky,, R. Handsher, and, Y. Barak. 1994. Neonatal coxsackievirus group B infections: experience of a single department of neonatology. Isr. J. Med. Sci. 30:371374.
114. Iwasaki, A.,, R. Welker,, S. Mueller,, M. Linehan,, A. Nomoto, and, E. Wimmer. 2002. Immunofluorescence analysis of poliovirus receptor expression in Peyer’s patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J. Infect. Dis. 186:585592.
115. Jaffe, M.,, I. Srugo,, E. Tirosh,, A. A. Colin, and, Y. Tal. 1989. The ameliorating effect of lumbar puncture in viral meningitis. Am. J. Dis. Child. 143:682685.
116. Jantausch, B. A.,, N. L. C. Luban,, L. Duffy, and, W. J. Rodriquez. 1995. Maternal plasma transfusion in the treatment of disseminated neonatal echovirus 11 infection. Pediatr. Infect. Dis. J. 14:154155.
117. Jartti, T.,, P. Lehtinen, and, T. Vuorinen. 2004. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg. Infect. Dis. 10:10951101.
118. Jarvis, W. R.,, and G. Tucker. 1981. Echovirus type 7 meningitis in young children. Am. J. Dis. Child. 135:10091012.
119. Jenista, J. A.,, L. E. Daizell,, P. W. Davidson, and, M. A. Menegus. 1984. Outcome studies of neonatal enterovirus infection. Pediatr. Res. 18:230A.
120. Jenista, J. A.,, K. R. Powell, and, M. A. Menegus. 1984. Epidemiology of neonatal enterovirus infection. J. Pediatr. 104:685690.
121. Johnson, G. M.,, G. A. McAbee,, E. D. Seaton, and, S. M. Lipson. 1992. Suspect value of non-CSF viral cultures in the diagnosis of enteroviral CNS infection in young infants. Dev. Med. Child Neurol. 34:876884.
122. Johnson, K. L.,, and P. Sarnow. 1995. Viral RNA synthesis, p. 95–112. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
123. Johnston, J. M.,, and J. C. Overall, Jr. 1989. Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection. Pediatr. Infect. Dis. J. 8:254256.
124. Junttila, N.,, N. Léveêque,, J. P. Kabue,, G. Cartet,, F. Mushiya,, J. J. Muyembe-Tamfum,, A. Trompette,, B. Lina,, L. O. Magnius,, J. J. Chomel, and, H. Norder. 2007. New enteroviruses, EV-93 and EV-94, associated with acute flaccid paralysis in the Democratic Republic of the Congo. J. Med. Virol. 79:393400.
125. Kantor, F. S.,, and G. D. Hsiung. 1962. Pleurodynia associated with echo virus type 8. N. Engl. J. Med. 266:661663.
126. Kaplan, M. H.,, S. W. Klein,, J. McPhee, and, R. G. Harper. 1983. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev. Infect. Dis. 5:10191032.
127. Kearns, G. L.,, S. M. Abdel-Rahman,, L. P. James,, D. L. Blowey,, J. D. Marshall,, T. G. Wells, and, R. F. Jacobs. 1999. Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Antimicrob. Agents Chemother. 43:634638.
128. Keeling, P.,, J. Jeffrey,, S. Caforio,, R. Taylor,, G. F. Bottazzo,, M. J. Davies, and, W. J. McKenna. 1992. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br. Heart J. 68:554559.
129. Kelly, S.,, W. Winkelstein, Jr., and, J. Winsser. 1957. Poliomyelitis and other enteric viruses in sewage. Am. J. Public Health Nations Health 47:7277.
130. Kessler, H. H.,, B. Santner,, H. Rabenau,, A. Berger,, A. Vince,, C. Lewinski,, B. Weber,, K. Pierer,, D. Stuenzner,, E. Marth, and, H. W. Doerr. 1997. Rapid diagnosis of enterovirus infection by a new one-step reverse transcription-PCR assay. J. Clin. Microbiol. 35:976977.
131. Kew, O.,, V. Morris-Glasgow,, M. Landaverde,, C. Burns,, J. Shaw,, Z. Garib,, J. André,, E. Blackman,, C. J. Freeman,, J. Jorba,, R. Sutter,, G. Tambini,, L. Venczel,, C. Pedreira,, F. Laender,, H. Shimizu,, T. Yoneyama,, T. Miyamura,, H. van Der Avoort,, M. S. Oberste,, D. Kilpatrick,, S. Cochi,, M. Pallansch, and, C. de Quadros. 2002. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356359.
132. Kew, O. M.,, R. W. Sutter,, E. M. de Gourville,, W. R. Dowdle, and, M. A. Pallansch. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59:587635.
133. Khetsuriani, N.,, A. Lamonte,, M. S. Oberste, and, M. Pallansch. 2006. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983–2003. Pediatr. Infect. Dis. J. 25:889893.
134. Kilpatrick, D. R.,, K. Ching,, J. Iber,, R. Campagnoli,, C. J. Freeman,, N. Mishrik,, H. M. Liu,, M. A. Pallansch, and, O. M. Kew. 2004. Multiplex PCR method for identifying recombinant vaccine-related polioviruses. J. Clin. Microbiol. 42:43134315.
135. Kilpatrick, D. R.,, B. Nottay,, C. F. Yang,, S. J. Yang,, E. Da Silva,, S. Penaranda,, M. Pallansch, and, O. Kew. 1998. Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J. Clin. Microbiol. 36:352357.
136. Kilpatrick, D. R.,, B. Nottay,, C.-F. Yang,, S.-J. Yang,, M. N. Mulders,, B. P. Holloway,, M. A. Pallansch, and, O. M. Kew. 1996. Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J. Clin. Microbiol. 34:29902996.
137. King, D. L.,, and D. T. Karzon. 1975. An epidemic of aseptic meningitis syndrome due to echo virus type 6. Pediatrics 53:432437.
138. Kinnunen, E.,, Hovi,, T. Stenvik,, O. Hellström,, J. Porras,, M. Kleemola, and, M. L. Kantanen. 1987. Localized outbreak of enteroviral meningitis in adults. Acta Neurol. Scand. 74:346351.
139. Klespies, S. L.,, D. E. Cebula,, C. L. Kelley,, D. Galehouse, and, C. C. Maurer. 1996. Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay. J. Clin. Microbiol. 34:14651467.
140. Kogon, A.,, I. Spigland,, T. E. Frothingham,, L. Elveback,, C. Williams,, C. E. Hall, and, J. P. Fox. 1969. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am. J. Epidemiol. 89:5161.
141. Kost, C. B.,, B. Rogers,, M. S. Oberste,, C. Robinson,, B. L. Eaves,, K. Leos,, S. Danielson,, M. Satya,, F. Weir, and, F. S. Nolte. 2007. Multicenter beta trial of the GeneXpert enterovirus assay. J. Clin. Microbiol. 45:10811086.
142. Lake, A. M.,, B. A. Lauer,, J. C. Clark,, R. L. Wesenberg, and, K. McIntosh. 1976. Enterovirus infections in neonates. J. Pediatr. 89:787791.
143. Landry, M. L.,, R. Garner, and, D. Ferguson. 2003. Rapid enterovirus RNA detection in clinical specimens by using nucleic acid sequence-based application. J. Clin. Microbiol. 41:346350.
144. Landry, M. L.,, R. Garner, and, D. Ferguson. 2003. Comparison of the NucliSens Basic kit (nucleic acid sequence-based amplification) and the Argene Biosoft Enterovirus Consensus reverse transcription-PCR assays for rapid detection of enterovirus RNA in clinical specimens. J. Clin. Microbiol. 41:50065010.
145. Landsteiner, K.,, and E. Popper. 1909. Uebertragung der Poliomyelitis acuta auf Affen. Z. Immunitaetsforsch. 2:377390.
146. Leon-Monzon, M. E.,, I. Illa, and, M. C. Dalakas. 1995. Expression of poliovirus receptor in human spinal cord and muscle. Ann. N. Y. Acad. Sci. 753:4857.
147. Lerner, A. M.,, J. O. Klein,, J. D. Cherry, and, M. Finland. 1963. New viral exanthems. N. Engl. J. Med. 269:678685.
148. Liljeqvist, J. A.,, T. Bergström,, S. Holmström,, A. Samuelson,, G. E. Yousef,, F. Waagstein, and, S. Jeansson. 1993. Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy. J. Med. Virol. 36:610.
149. Lim, K. A.,, and M. Benyesh-Melnick. 1960. Typing of viruses by combinations of antisera pools. Application to typing of enteroviruses (coxsackie and echo). J. Immunol. 84:309317.
150. Lipson, S. M.,, R. Waiderman,, P. Costello, and, K. Szabo. 1988. Sensitivity of rhabdomyosarcoma and guinea pig embryo cell cultures to field isolates of difficult-to-cultivate group A coxsackieviruses. J. Clin. Microbiol. 26:12981303.
151. Lönnrot, M.,, M. Knip,, M. Roivaninen,, P. Koskela,, H. K. Akerblom, and, H. Hyöty. 1998. Onset of type 1 diabetes mellitus in infancy after enterovirus infections. Diabet. Med. 15:431434.
152. Lucchesi, P. F. 1934. Poliomyelitis: a study of 410 patients at the Philadelphia Hospital for Contagious Diseases. Am. J. Med. Sci. 4:515523.
153. Magoffin, R. L.,, and E. H. Lennette. 1962. Nonpolioviruses and paralytic disease. Calif. Med. 97:17.
154. Mahon, N. G.,, B. Zal,, G. Arno,, P. Risley,, J. Pinto-Basto,, W. J. McKenna,, M. J. Davies, and, C. Baboonian. 2001. Absence of viral nucleic acids in early and late dilated cardiomyopathy. Heart 86:687692.
155. Martino, T. A.,, P. Liu,, M. Petric, and, M. J. Sole. 1995. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies, p. 291–351. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
156. McKinney, R. E.,, Jr., S. L. Katz, and, C. M. Wilfert. 1987. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis. 9:334356.
157. McLaughlin, J. B.,, B. D. Gessner,, T. V. Lynn,, E. A. Funk, and, J. P. Middaugh. 2004. Association of regulatory issues with an echovirus 18 meningitis outbreak at a children’s summer camp in Alaska. Pediatr. Infect. Dis. J. 23:875877.
158. Melnick, J. L. 1989. Enteroviruses, p. 191–263. In A. S. Evans (ed.), Viral Infections of Humans, Epidemiology and Control, 3rd ed. Plenum, New York, NY.
159. Melnick, J. L.,, R. O. Proctor,, A. R. Ocampo,, A. R. Diwan, and, E. Ben-Porath. 1966. Free and bound virus in serum after administration of oral poliovirus vaccine. Am. J. Epidemiol. 84:329342.
160. Melnick, J. L.,, V. Rennick,, B. Hampil,, N. J. Schmidt, and, H. H. Ho. 1973. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull. W. H. O. 48:263268.
161. Melnick, J. L.,, N. J. Schmidt,, B. Hampil, and, H. H. Ho. 1977. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 19 group A coxsackievirus serotypes. Intervirology 8:172181.
162. Melnick, J. L.,, I. Tagaya, and, H. Von Magnus. 1974. Enteroviruses 69, 70, and 71. Intervirology 4:369370.
163. Mendelsohn, C. L.,, E. Wimmer, and, V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell 56:855865.
164. Minor, P. D. 1992. The molecular biology of poliovaccines. J. Gen. Virol. 73:30653077.
165. Minor, P. D.,, M. Ferguson,, D. M. Evans,, J. W. Almond, and, J. P. Icenogle. 1986. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 67:12831291.
166. Minor, P. D.,, A. John,, M. Ferguson, and, J. P. Icenogle. 1986. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J. Gen. Virol. 67:693706.
167. Mintz, L.,, and W. L. Drew. 1980. Relation of culture site to the recovery of nonpolio enteroviruses. Am. J. Clin. Pathol. 74:324326.
168. Mitchell, J. R.,, M. W. Presnell,, E. W. Akin,, J. M. Cummins, and, O. C. Liu. 1966. Accumulation and elimination of poliovirus by the eastern oyster. Am. J. Epidemiol. 84:4050.
169. Modlin, J. F.,, R. Dagan,, L. E. Berlin,, D. M. Virshup,, R. H. Yolken, and, M. Menegus. 1991. Focal encephalitis with enterovirus infections. Pediatrics 88:841845.
170. Modlin, J. F. 1986. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev. Infect. Dis. 8:918926.
171. Moore, M. 1982. Enteroviral disease in the United States, 1970–1979. J. Infect. Dis. 146:103108.
172. Morens, D. M.,, and M. A. Pallansch. 1995. Epidemiology, p. 3–23. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press. Washington, DC.
173. Moses, E. B.,, A. G. Dean,, M. H. Hatch, and, A. L. Barron. 1977. An outbreak of aseptic meningitis in the area of Fort Smith, Arkansas, 1975, due to echovirus type 4. J. Ark. Med. Soc. 74:121125.
174. Muckelbauer, J. K.,, M. Kremer,, I. Minor,, G. Diana,, F. J. Dutko,, J. Groarke,, D. C. Pevear, and, M. G. Rossmann. 1995. The structure of coxsackievirus B3 at 3.5 A resolution. Structure 3:653667.
175. Muir, P.,, F. Nicholson,, M. K. Sharief,, E. J. Thompson,, N. J. Cairns,, P. Lantos,, G. T. Spencer,, H. J. Kaminski, and, J. E. Banatvala. 1995. Evidence for persistent enterovirus infection of the central nervous system in patients with previous paralytic poliomyelitis. Ann. N. Y. Acad. Sci. 753:219232.
176. Nathanson, N.,, and D. Bodian. 1961. Experimental poliomyelitis following intramuscular virus injection. 1. The effect of neural block on a neurotropic and a pantropic strain. Bull. Johns Hopkins Hosp. 108:308319.
177. Nathanson, N.,, and A. Langmuir. 1963. The Cutter incident: poliomyelitis following formaldehydeinactivated poliovirus vaccination in the United States during the spring of 1955. III. Comparison of the clinical character of vaccinated and contact cases occurring after use of high rate lots of Cutter vaccine. Am. J. Hyg. 78:6181.
178. Nathanson, N.,, and J. R. Martin. 1979. The epidemiology of poliomyelitis—enigmas surrounding its appearance, epidemicity, and disappearance. Am. J. Epidemiol. 110:672692.
179. Newcombe, N. G.,, L. G. Beagley,, D. Christiansen,, B. E. Loveland,, E. S. Johansson,, K. W. Beagley,, R. D. Barry, and, D. R. Shafren. 2004. Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivity. J. Virol. 78:1267712682.
180. Nix, W. A.,, M. S. Oberste, and, M. A. J. Pallansch. 2006. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. Clin. Microbiol. 44:26982704.
181. Norder, H.,, L. Bjerregaard,, L. Magnius,, B. Lina,, M. Aymard, and, J. J. Chomel. 2003. Sequencing of ‘untypable’ enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types. J. Gen. Virol. 84:827836.
182. Oberste, M. S. 2001. Molecular identification of new picornaviruses and characterization of a proposed enterovirus 73 serotype. J. Gen. Virol. 82:409416.
183. Oberste, M. S.,, K. Maher,, M. R. Flemister,, G. Marchetti,, D. R. Kilpatrick, and, M. A. Pallansch. 2000. Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J. Clin. Microbiol. 38:11701174.
184. Oberste, M. S.,, K. Maher,, D. R. Kilpatrick, and, M. A. Pallansch. 1999. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol. 73:19411948.
185. Oberste, M. S.,, K. Maher,, D. R. Kilpatrick,, M. R. Flemister,, B. A. Brown, and, M. A. Pallansch. 1999. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 37:12881293.
186. Oberste, M. S.,, K. Maher,, S. M. Michele,, G. Belliot,, M. Uddin, and, M. A. Pallansch. 2005. Enteroviruses 76, 89, 90 and 91 represent a novel group within the species Human enterovirus A. J. Gen. Virol. 86:445451.
187. Oberste, M. S.,, K. Maher,, W. A. Nix,, S. M. Michele,, M. Uddin,, D. Schnurr,, S. al-Busaidy,, C. Akoua-Koffi, and, M. A. Pallansch. 2007. Molecular identification of 13 new enterovirus types, EV79-88, EV97, and EV100-101, members of the species Human Enterovirus B. Virus Res. 128:3442.
188. Oberste, M. S.,, K. Maher,, A. J. Williams,, N. Dybdahl-Sissoko,, B. A. Brown,, M. S. Gookin,, S. Peñaranda,, N. Mishrik,, M. Uddin, and, M. A. Pallansch. 2006. Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enteroviruses. J. Gen. Virol. 87:119128.
189. Oberste, M. S.,, S. M. Michele,, K. Maher,, D. Schnurr,, D. Cisterna,, N. Junttila,, M. Uddin,, J. J. Chomel,, C. S. Lau,, W. Ridha,, S. al-Busaidy,, H. Norder,, L. O. Magnius, and, M. A. Pallansch. 2004. Molecular identification and characterization of two proposed new enterovirus serotypes, EV74 and EV75. J. Gen. Virol. 85:32053212.
190. Oberste, M. S.,, W. A. Nix,, K. Maher, and, M. A. Pallansch. 2003. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J. Clin. Virol. 26:375377.
191. Ohka, S.,, W. X. Yang,, E. Terada,, K. Iwasaki, and, A. Nomoto. 1998. Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology 250:6775.
192. Pallansch, M. A.,, and R. P. Roos. 2007. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 839–893. In D. M. Knipe,, P. M. Howley,, D. E. Griffin,, R. A. Lamb,, M. A. Martin,, B. Roizman, and, S. E. Straus (ed.), Fields Virology, 5th ed. Lippincott Williams % Wilkins, Philadelphia, PA.
193. Parrott, R. H.,, S. Ross,, F. G. Burke, and, E. C. Rice. 1951. Herpangina: clinical studies of a specific infectious disease. N. Engl. J. Med. 245:275280.
194. Patriarca, P. A.,, I. M. Onorato,, V. E. F. Sklar,, L. B. Schonberger,, R. M. Kaminski,, M. H. Hatch,, D. M. Morens, and, R. K. Forster. 1983. Acute hemorrhagic conjunctivitis. Investigation of a large-scale community outbreak in Dade County, Florida. JAMA 249:12831289.
195. Paul, J. R.,, and D. M. Horstmann. 1955. A survey of poliomyelitis virus antibodies in French Morocco. Am. J. Trop. Med. Hyg. 4:512524.
196. Peigue-Lafeuille, H.,, N. Croquez,, H. Laurichesse,, P. Clavelou,, O. Aumaître,, J. Schmidt,, M. Maillet-Vioud,, C. Henquell,, C. Archimbaud,, J. L. Bailly, and, M. Chambon. 2002. Enterovirus meningitis in adults in 1999–2000 and evaluation of clinical management. J. Med. Virol. 67:4753.
197. Pelletier, J.,, and N. Sonenberg. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320325.
198. Pevear, D. C.,, M. J. Fancher,, P. J. Felock,, M. G. Rossmann,, M. S. Miller,, G. D. Diana,, A. M. Treasurywala,, M. A. McKinlay, and, F. J. Dutko. 1989. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J. Virol. 63:20022007.
199. Pevear, D. C.,, T. M. Tull,, M. E. Seipel, and, J. M. Groarke. 1999. Activity of pleconaril against enteroviruses. Antimicrob. Agents Chemother. 43:21092115.
200. Pichichero, M. E.,, S. McLinn,, H. A. Rotbart,, M. A. Menegus,, M. Cascino, and, B. E. Reidenberg. 1998. Clinical and economic impact of enterovirus illness in private pediatric practice. Pediatrics 102:11261134.
201. Prather, S. L.,, R. Dagan,, J. A. Jenista, and, M. A. Menegus. 1984. The isolation of enteroviruses from blood: a comparison of four processing methods. J. Med. Virol. 14:221227.
202. Price, R. A.,, J. H. Garcia, and, W. A. Rightsel. 1970. Choriomeningitis and myocarditis in an adolescent with isolation of coxsackie B-5 virus. Am. J. Clin. Pathol. 53:825831.
203. Racaniello, V. R. 1995. Early events in infection: receptor binding and cell entry, p. 73–93. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
204. Racaniello, V. R. 2007. Picornaviridae: the viruses and their replication, p. 795–838. In D. M. Knipe,, P. M. Howley,, D. E. Griffin,, R. A. Lamb,, M. A. Martin,, B. Roizman, and, S. E. Straus (ed.), Fields Virology, 5th ed. Lippincott Williams % Wilkins, Philadelphia, PA.
205. Racaniello, V. R. 2006. One hundred years of poliovirus pathogenesis. Virology 344:916.
206. Ramers, C.,, G. Billman,, M. Hartin,, S. Ho, and, M. H. Sawyer. 2000. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 283:26802685.
207. Rantakallio, P.,, M. Leskinen, and, L. von Wendt. 1986. Incidence and prognosis of central nervous system infections in a birth cohort of 12,000 children. Scand. J. Infect. Dis. 18:287294.
208. Ray, C. G.,, R. H. McCollough,, I. L. Doto,, J. C. Todd,, W. P. Glezen, and, T. D. Chin. 1966. Echo 4 illness. Epidemiological, clinical and laboratory studies of an outbreak in a rural community. Am. J. Epidemiol. 84:253267.
209. Reimann, B.,, R. Zell, and, R. Kandolf. 1991. Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigenic chimera. J. Virol. 65:34753480.
210. Ren, R.,, and V. Racaniello. 1992. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 66:296304.
211. Rewers, M.,, and M. Atkinson. 1995. The possible role of enteroviruses in diabetes mellitus, p. 353–395. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
212. Rigonan, A. S.,, L. Mann, and, T. Chonmaitree. 1998. Use of monoclonal antibodies to identify serotypes of enterovirus isolates. J. Clin. Microbiol. 36:18771881.
213. Roivainen, M.,, T. Hyypiä,, L. Piirainen,, N. Kalkkinen,, G. Stanway, and, T. Hovi. 1995. The coxsackievirus A9 RGD motif is not essential for virus viability. J. Virol. 69:80358040.
214. Rombaut, B.,, R. Vrijsen, and, A. Boeye. 1985. Comparison of arildone and 3-methylquercetin as stabilizers of poliovirus. Antivir. Res. 1985(Suppl. 1):6773.
215. Romero, J. R. 1999. Reverse-transcription-polymerase chain reaction detection of the enteroviruses: overview and clinical utility in pediatric enteroviral infections. Arch. Pathol. Lab. Med. 123:11611169.
216. Romero, J. R. 2006. Enteroviruses and parechoviruses, p. 1392–1404. In P. R. Murray,, E. J. Baron,, J. H. Jorgensen,, M. L. Landry, and, M. A. Pfaller (ed.), Manual of Clinical Microbiology, 9th ed. ASM Press, Washington, DC.
217. Romero, J. R.,, and H. A. Rotbart. 1994. PCR-based strategies for the detection of human enteroviruses, p. 341–374. In G. D. Ehrlich, and, S. Greenberg (ed.), PCR-Based Diagnostics in Infectious Disease. Blackwell Scientific Publications, Boston, MA.
218. Rorabaugh, M. L.,, L. E. Berlin,, L. Rosenberg, and, J. Modlin. 1992. Absence of neurodevelopmental sequelae from aseptic meningitis. Pediatr. Res. 30:177A.
219. Rorabaugh, M. L.,, L. E. Berlin,, F. Heldrich,, K. Roberts,, L. A. Rosenberg,, T. Doran, and, J. F. Modlin. 1993. Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 92:206211.
220. Rotbart, H. A. 1995. Meningitis and encephalitis, p. 271–289. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
221. Rotbart, H. A. 1997. Viral meningitis and the aseptic meningitis syndrome, p. 23–47. In W. M. Scheld,, R. J. Whitley, and, D. T. Durack (ed.), Infections of the Central Nervous System, 2nd ed. Lippincott-Raven, Philadelphia, PA.
222. Rotbart, H. A. 1990. Enzymatic RNA amplification of the enteroviruses. J. Clin. Microbiol. 28:438442.
223. Rotbart, H. A. 1990. Diagnosis of enteroviral meningitis with the polymerase chain reaction. J. Pediatr. 117:8589.
224. Rotbart, H. A.,, P. J. Brennan,, K. H. Fife,, J. R. Romero,, J. A. Griffin,, M. A. McKinlay, and, F. G. Hayden. 1998. Enterovirus meningitis in adults. Clin. Infect. Dis. 27:896898.
225. Rotbart, H. A. 1999. Enteroviruses, p. 990–998. In P. R. Murray,, E. J. Baron,, M. A. Pfaller,, F. C. Tenover, and, R. H. Yolken (ed.), Manual of Clinical Microbiology, 7th ed. ASM Press, Washington, DC.
226. Rotbart, H. A.,, J. P. Kinsella, and, R. L. Wasserman. 1990. Persistent enterovirus infection in culture-negative meningoencephalitis—demonstration by enzymatic RNA amplification. J. Infect. Dis. 161:787791.
227. Rotbart, H. A.,, G. H. McCracken,, R. J. Whitley,, J. F. Modlin,, M. Cascino,, S. Shah, and, D. Blum. 1999. Clinical significance of enteroviruses in serious summer febrile illnesses of children. Pediatr. Infect. Dis. J. 18:869874.
228. Rotbart, H. A.,, A. D. B. Webster, and Pleconaril Treatment Registry Group. 2001. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin. Infect. Dis. 32:228235.
229. Russell, W. R. 1947. Poliomyelitis; pre-paralytic stage and effect of physical activity on severity of paralysis. Br. Med. J. 2:1023.
230. Russell, W. R. 1949. Paralytic poliomyelitis. The early symptoms and the effect of physical activity on the course of disease. Br. Med. J. 1:465471.
231. Sabin, A. B.,, and R. Ward. 1941. Flies as carriers of poliomyelitis virus in urban epidemics. Science 94:590591.
232. Sabin, A. B.,, and R. Ward. 1941. The natural history of human poliomyelitis. I. Distribution of virus in nervous and non-nervous tissues. J. Exp. Med. 73:771793.
233. Sawyer, L. A.,, R. C. Hershow,, M. A. Pallansch,, D. B. Fishbein,, P. F. Pinsky,, S. F. Broerman,, B. B. Grimm,, L. J. Anderson,, D. B. Hall, and, L. B. Schonberger. 1989. An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant. Am. J. Epidemiol. 130:11871198.
234. Sawyer, M. H.,, D. Holland,, N. Aintablian,, J. D. Connor,, E. F. Keyser, and, N. J. Waecker, Jr. 1994. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr. Infect. Dis. J. 13:177182.
235. Sawyer, M. H.,, X. Saez-Llorenz,, C. L. Aviles,, M. O’Ryan, and, J. Romero. 1999. Oral pleconaril reduces the duration and severity of enteroviral meningitis in children. Pediatr. Res. 45(Part 2):173A.
236. Schiff, G.,, and J. Sherwood. 2000. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J. Infect. Dis. 181:2026.
237. Schlegel, A.,, and K. Kirkegaard. 1995. Cell biology of enterovirus infection, p. 135–154. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, DC.
238. Sells, C. J.,, R. L. Carpenter, and, C. G. Ray. 1975. Sequelae of central-nervous-system enterovirus infections. N. Engl. J. Med. 293:14.
239. Seme, K.,, T. Mocilnik,, K. F. Komlos,, A. Doplihar,, D. H. Persing, and, M. Poljak. 2008. GeneXpert enterovirus assay: one-year experience in a routine laboratory setting and evaluation on three proficiency panels. J. Clin. Microbiol. 46:15101513.
240. Shafran, S. D.,, W. Halota,, D. Gilbert,, J. Bernstein,, H. Meislin, and, M. Reiss. 1999. Pleconaril is effective for enteroviral meningitis in adolescents and adults: a randomized placebo-controlled multicenter trial, abstr. 1904. Abstr. 39th Intersci. Conf. Antimicrob. Agents Che-mother. American Society for Microbiology, Washington, DC.
241. Sharief, M. K.,, R. Hentges, and, M. Ciardi. 1991. Intrathecal immune response in patients with the postpolio syndrome. N. Engl. J. Med. 325:749755.
242. Sicinski, P.,, J. Rowinski,, J. B. Warchok,, Z. Jarzabek,, W. Gur,, B. Szczygiel,, K. Bielechi, and, G. Koch. 1990. Poliovirus type 1 enters the human host through intestinal M cells. Gastroenterology 98:5658.
243. Singer, J. I.,, P. R. Maur,, J. P. Riley, and, P. B. Smith. 1980. Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J. Pediatr. 96:559563.
244. Solomon, P.,, L. Weinstein, and, T. W. Chang. 1959. Epidemiologic, clinical and laboratory features of an epidemic of type 9 Echo virus meningitis. J. Pediatr. 55:609619.
245. Stanway, G.,, F. Brown,, P. Christian,, T. Hovi,, T. Hyypiä,, A. M. Q. King,, N. J. Knowles,, S. M. Lemon,, P. D. Minor,, M. A. Pallansch,, A. C. Palmenberg, and, T. Skern. 2005. Family Picornaviridae, p. 757–778. In C. M. Fauquet,, M. A. Mayo,, J. Maniloff,, U. Desselberger, and, L. A. Ball (ed.), Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses. Elsevier/Academic Press, San Diego, CA.
246. Stellrecht, K. A.,, I. Harding,, A. M. Woron,, M. L. Lepow, and, R. A. Venezia. 2002. The impact of an enteroviral RT-PCR assay on the diagnosis of aseptic meningitis and patient management. J. Clin. Virol. 1:S19S26.
247. Stewart, S.,, and B. Semler. 1997. RNA determinants of picornavirus cap independent translation initiation. Semin. Virol. 8:242255.
248. Strebel, P. M.,, N. Ion-Nedelcu,, A. L. Baughman,, R. W. Sutter, and, S. L. Cochi. 1995. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine—a risk factor for vaccine-associated paralytic poliomyelitis. N. Engl. J. Med. 332:500506.
249. Strikas, R. A.,, L. J. Anderson, and, A. Parker. 1986. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970–1983. J. Infect. Dis. 153:346351.
250. Sumaya, C. V.,, and L. I. Corman. 1982. Enteroviral meningitis in early infancy: significance in community outbreaks. Pediatr. Infect. Dis. 3:151154.
251. Sutinen, S.,, J. L. Kalliomaki,, R. Pohjonen, and, R. Vastamaki. 1971. Fatal generalized coxsackie B3 virus infection in an adolescent with successful isolation of the virus from pericardial fluid. Ann. Clin. Res. 3:241246.
252. Sutter, R. W.,, P. A. Patriarca,, A. J. Suleiman,, S. Brogan,, P. G. Malankar,, S. L. Cochi,, A. A. Al-Ghassani, and, M. S. el-Bualy. 1992. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J. Infect. Dis. 165:444449.
253. Sylvest, E. 1934. Epidemic Myalgia: Bornholm Disease. Oxford University Press, London, England. (Translated by H. Andersen.)